AINOSTICS is highlighted in a recent Radar report by Frost & Sullivan, titled "Neuroimaging Technology Advances and Growth...

We are delighted to be taking part in a unique 6-month accelerator programme that is organised by Innovate UK and the Texas Medical...

Our team will be attending the Radiological Society of North America scientific assembly and annual meeting in Chicago from November 27th...

We are excited to announce that our CEO, Dr Hojjat Azadbakht has been nominated for the Prolific North Tech Entrepreneur of the Year Award.

We are thrilled to announce that AINOSTICS has been awarded Breakthrough Device Designation by the US Food and Drug Administration (FDA)...

We are excited to announce that as part of a National Institute of Health and Care Research (NIHR) funded study and in partnership with...

We are pleased to announce that our CEO, Dr Hojjat Azadbakht, has been named as one of the recipients of the highly competitive and...

We are delighted to announce that AINOSTICS has been accepted onto the London & Partners Mayor’s International Business Programme,...

We have just secured approximately $2,600,000 in funding to accelerate the development of our ground-breaking technologies for performing...

Our CEO, Dr Hojjat Azadbakht, will be speaking at AICon 2021, The premier conference on artificial intelligence in the North of the UK....